Zimmer Biomet Holdings (ZBH) EBIT Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -24.91% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 4.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47% |
| Dec 31, 2025 | 95.39% |
| Sep 30, 2025 | 12.72% |
| Jun 30, 2025 | 2.22% |
| Mar 31, 2025 | 13.79% |
| Dec 31, 2024 | 42.72% |
| Sep 30, 2024 | 4.78% |
| Jun 30, 2024 | 16.05% |
| Mar 31, 2024 | 237.77% |
| Dec 31, 2023 | -4.88% |
| Sep 30, 2023 | -3.77% |
| Jun 30, 2023 | 57.67% |
| Mar 31, 2023 | 39.55% |
| Dec 31, 2022 | -27.73% |
| Sep 30, 2022 | -0.07% |
| Jun 30, 2022 | 11.12% |
| Mar 31, 2022 | -17.25% |
| Dec 31, 2021 | 29.45% |
| Sep 30, 2021 | 2.86% |
| Jun 30, 2021 | -8.76% |